Fig. 6
From: Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis
Results of phenotypic scanning. snp, single nucleotide polymorphisms used in MR; OR, odds ratio.
Fig. 6 | Scientific Reports
From: Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis
Results of phenotypic scanning. snp, single nucleotide polymorphisms used in MR; OR, odds ratio.
